Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1983;68:131-138

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smalling, R. W.
Right arrow Articles by Gould, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smalling, R. W.
Right arrow Articles by Gould, K. L.

Circulation, Vol 68, 131-138, Copyright © 1983 by American Heart Association


ARTICLES

Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarction

RW Smalling, F Fuentes, MW Matthews, GC Freund, CH Hicks, LA Reduto, WE Walker, RP Sterling and KL Gould

One hundred eighty-eight patients with acute myocardial infarction were studied prospectively from August 1980 to September 1982. One hundred thirty-six of these patients were entered into a intracoronary streptokinase study after informed consent was obtained. The remaining 52 patients, who either met exclusion criteria for the study or refused to participate, served as a control group and were treated as those in the study group except that they did not undergo emergency cardiac catheterization. Left ventricular function was determined in both groups by gated radionuclide ejection fraction (EF) on admission to the hospital, at discharge, and 6 months after discharge. With successful reperfusion up to 18 hr after onset of chest pain, mean left ventricular function in the study group improved (EF 39 +/- 13% on admission and 46 +/- 12% at discharge; p less than .001). Mean EF in control patients and those not achieving reperfusion did not change from admission to discharge. Mean EF at 6 month follow-up was not significantly different than at discharge in the study group or the control group. Total cardiac mortality in the control group was 19% compared with 10% in the study group (p = .06, NS). When patients admitted in pulmonary edema or shock (Killip class III or IV) were excluded from both groups, total cardiac mortality in the study group was significantly lower (4%) compared with in the control group (12.5%, p less than .05. The administration of intracoronary streptokinase during evolving myocardial infarction up to 18 hr after onset of chest pain may result in decreased mortality and sustained improvement in left ventricular function.


This article has been cited by other articles:


Home page
HeartHome page
M Saha, R Zbinden, S R Redwood, and M S Marber
Stem cells to repair the broken heart: much ado about nothing?
Heart, December 1, 2006; 92(12): 1717 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Intra-arterial Thrombolysis
AJNR Am. J. Neuroradiol., September 1, 2001; 22(2007): 18S - 21S.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Hosokawa, F. H. Sheehan, and T. Suzuki
Measurement of postsystolic shortening to assess viability and predict recovery of left ventricular function after acute myocardial infarction
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1842 - 1849.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. Smalling, S. Feld, N. Ramanna, J. Amirian, P. Felli, W. K. Vaughn, C. Swenson, and A. Janoff
Infarct Salvage With Liposomal Prostaglandin E1 Administered by Intravenous Bolus Immediately Before Reperfusion in a Canine Infarction-Reperfusion Model
Circulation, August 15, 1995; 92(4): 935 - 943.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
D. C. Babalis, G. N. Boutos, E. K. Iliodromitis, A. K. Trovas, and E. M. Vorides
Precordial ECG Mapping in Acute Myocardial Infarction (AMI) After Intravenous Infusion of Streptokinase (s)
Angiology, December 1, 1989; 40(12): 1040 - 1047.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
B. I. Salem, S. Gowda, and M. Haikal
Reduced In-Hospital Mortality Following Intracoronary Streptokinase Treatment of Acute Myocardial Infarction
Vascular and Endovascular Surgery, May 1, 1987; 21(3): 215 - 219.
[Abstract] [PDF]


Home page
J Intensive Care MedHome page
P. L. Zwerner and J. M. Gore
Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction
J Intensive Care Med, December 1, 1986; 1(6): 302 - 318.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
G. C. Timmis, D. C. Westveer, A. M. Hauser, J. R. Stewart, V. Gangadharan, R. G. Ramos, and S. Gordon
The Influence of Infarction Site and Size on the Ventricular Response to Coronary Thrombolysis
Arch Intern Med, December 1, 1985; 145(12): 2188 - 2193.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. I. Dunn and R. J. Dreiling
Streptokinase
Arch Intern Med, August 1, 1985; 145(8): 1381 - 1383.
[Abstract] [PDF]